Autohemotherapy combined with other external treatments of Traditional Chinese Medicine for chronic urticaria: a systematic review and meta-analysis - Report - MDSpire

Autohemotherapy combined with other external treatments of Traditional Chinese Medicine for chronic urticaria: a systematic review and meta-analysis

  • By

  • Jinchu Zhou

  • Boya Zhang

  • Haiying Liang

  • Xin Huang

  • Xingwei Liu

  • Yi Tong

  • Zhixuan Ai

  • Xinsheng Chen

  • June 10, 2026

  • 0 min

Share

Clinical Report: Efficacy and Safety of Autohemotherapy for Chronic Urticaria

Overview

This systematic review and meta-analysis evaluate the efficacy and safety of autohemotherapy (AHT) combined with Traditional Chinese Medicine (TCM) external treatments for chronic urticaria (CU). The intervention group showed significant improvements in overall response rate, recurrence rate, serum IgE levels, pruritus severity, and wheal duration compared to the control group.

Background

Chronic urticaria (CU) is a recurrent skin condition that significantly impacts patients' quality of life and mental health. Current treatments primarily involve second-generation antihistamines, but many patients do not achieve adequate control. Exploring additional treatment options, such as AHT combined with TCM, is essential for improving patient outcomes.

Data Highlights

OutcomeIntervention GroupControl GroupRR/SMD (95% CI)p-value
Overall Response RateBetterStandard Treatment1.17 (1.10–1.24)< 0.001
Recurrence RateLowerStandard Treatment0.31 (0.23–0.42)< 0.001
Serum IgE LevelLowerStandard Treatment−1.33 (−1.76 to −0.91)< 0.001
Pruritus SeverityLowerStandard Treatment−1.36 (−2.17 to −0.54)< 0.001
Wheal DurationLowerStandard Treatment−3.05 (−6.05 to −0.06)< 0.005

Key Findings

  • The overall response rate was significantly better in the intervention group (RR: 1.17; p < 0.001).
  • The intervention group showed a significantly lower recurrence rate (RR: 0.31; p < 0.001).
  • Serum IgE levels were significantly reduced in the intervention group (SMD: −1.33; p < 0.001).
  • Pruritus severity showed significant improvement (SMD: −1.36; p < 0.001), though results were not robust.
  • Wheal duration was significantly reduced (SMD: −3.05; p < 0.005), but results showed significant publication bias.

Clinical Implications

The findings suggest that AHT combined with TCM external treatments may offer a beneficial alternative for patients with chronic urticaria who do not respond adequately to conventional therapies. However, the methodological limitations and high clinical heterogeneity among studies warrant cautious interpretation of these results.

Conclusion

Autohemotherapy combined with TCM external treatments appears to improve clinical efficacy and reduce recurrence rates in chronic urticaria. Further rigorous studies are needed to confirm these findings.

Related Resources & Content

  1. Frontiers in Medicine, 2026 -- Autohemotherapy combined with other external treatments of traditional Chinese medicine for chronic urticaria: A systematic review and meta-analysis
  2. Frontiers in Neurology — Efficacy and safety of ozone autohemotherapy for zoster-associated pain: a meta-analysis and trial sequential analysis
  3. Frontiers in Immunology — Electroacupuncture at LI11 and SP10 is associated with alleviation of acute urticaria-like reactions in passive cutaneous anaphylaxis: an exploratory analysis of complement-related proteins and multiscale omics
  4. Frontiers in Medicine — Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial
  5. Frontiers in Medicine — Impacts of specific acupuncture techniques combined with infrared radiation therapy on the symptom improvement and quality of life of patients with allergic rhinitis
  6. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
  7. Press Release
  8. Novel Drug Approvals for 2025 | FDA
  9. Remibrutinib in Chronic Spontaneous Urticaria - PubMed
  10. 中国荨麻疹诊疗指南(2022版)
  11. Comparative efficacy of omalizumab, dupilumab, and remibrutinib in chronic spontaneous urticaria: a network meta-analysis of randomized control trials - PubMed
  12. Frontiers | Autohemotherapy combined with other external treatments of traditional Chinese medicine for chronic urticaria: A systematic review and meta-analysis
  13. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials - PubMed
  14. Drug Trials Snapshot: RHAPSIDO | FDA
  15. Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success - PMC

Original Source(s)

Related Content